Predictive Oncology Inc. – NASDAQ:POAI

Predictive Oncology stock price today

$0.9
-0.08
-9.09%
Financial Health
0
1
2
3
4
5
6
7
8
9

Predictive Oncology stock price monthly change

-11.61%
month

Predictive Oncology stock price quarterly change

-11.61%
quarter

Predictive Oncology stock price yearly change

-69.91%
year

Predictive Oncology key metrics

Market Cap
4.56M
Enterprise value
N/A
P/E
-0.82
EV/Sales
-0.66
EV/EBITDA
0.03
Price/Sales
9.32
Price/Book
0.93
PEG ratio
-0.01
EPS
-3.65
Revenue
1.95M
EBITDA
-13.87M
Income
-14.78M
Revenue Q/Q
74.92%
Revenue Y/Y
36.97%
Profit margin
-1802.31%
Oper. margin
-1159.36%
Gross margin
65.84%
EBIT margin
-1159.36%
EBITDA margin
-708.06%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Predictive Oncology stock price history

Predictive Oncology stock forecast

Predictive Oncology financial statements

Predictive Oncology Inc. (NASDAQ:POAI): Profit margin
Jun 2023 490.11K -3.92M -800.51%
Sep 2023 715.05K -3.16M -442.41%
Dec 2023 335.03K -3.47M -1037.32%
Mar 2024 419.64K -4.21M -1005.33%
Predictive Oncology Inc. (NASDAQ:POAI): Analyst Estimates
2025 113.2M 28.10M 24.83%
  • Analysts Price target

  • Financials & Ratios estimates

Predictive Oncology Inc. (NASDAQ:POAI): Debt to assets
Jun 2023 20967006 6.26M 29.87%
Sep 2023 18166868 6.51M 35.86%
Dec 2023 14417249 6.14M 42.63%
Mar 2024 10601187 6.54M 61.76%
Predictive Oncology Inc. (NASDAQ:POAI): Cash Flow
Jun 2023 -3.57M -259.10K 0
Sep 2023 -3.10M -3.92K 260.22K
Dec 2023 -3.08M 7.29K -111.32K
Mar 2024 -3.41M -3.03K -112.37K

Predictive Oncology alternative data

Predictive Oncology Inc. (NASDAQ:POAI): Employee count
Aug 2023 31
Sep 2023 31
Oct 2023 31
Nov 2023 31
Dec 2023 31
Jan 2024 31
Feb 2024 31
Mar 2024 31
Apr 2024 31
May 2024 34
Jun 2024 34
Jul 2024 34

Predictive Oncology other data

1.80% -4.11%
of POAI is owned by hedge funds
1.31M -3.31M
shares is hold by hedge funds

Predictive Oncology Inc. (NASDAQ:POAI): Insider trades (number of shares)
Period Buy Sel
Nov 2022 10000 0
Dec 2022 19795 0
Sep 2023 0 10000
Transaction Date Insider Security Shares Price per share Total value Source
Option
MYERS ROBERT L officer: CHIEF FI.. Common Stock 1,667 N/A N/A
Sale
NUZUM CHARLES LEE SR director
Common Stock 10,000 $3.04 $30,390
Purchase
HANDLEY DANIEL E director
Common Stock 6,000 $0.41 $2,460
Purchase
VENNARE RAYMOND F director
Common Stock 400 $0.52 $208
Purchase
VENNARE RAYMOND F director
Common Stock 4,600 $0.52 $2,374
Purchase
MYERS ROBERT L officer: CHIEF FI.. Common Stock 8,795 $0.57 $5,004
Purchase
HANDLEY DANIEL E director
Common Stock 10,000 $0.36 $3,580
Option
MYERS ROBERT L officer: CHIEF FI.. Common Stock 33,333 N/A N/A
Option
MYERS ROBERT L officer: CHIEF FI.. Restricted Stock Units 33,333 N/A N/A
Purchase
HANDLEY DANIEL E director
Common Stock 2,550 $0.38 $956
Wednesday, 13 November 2024
globenewswire.com
Thursday, 5 September 2024
globenewswire.com
Wednesday, 14 August 2024
seekingalpha.com
globenewswire.com
Wednesday, 7 August 2024
globenewswire.com
Friday, 26 July 2024
globenewswire.com
Thursday, 25 July 2024
investorplace.com
globenewswire.com
Tuesday, 11 June 2024
globenewswire.com
Tuesday, 4 June 2024
globenewswire.com
Wednesday, 29 May 2024
globenewswire.com
Tuesday, 28 May 2024
globenewswire.com
Wednesday, 15 May 2024
seekingalpha.com
globenewswire.com
Friday, 10 May 2024
GlobeNewsWire
Wednesday, 8 May 2024
InvestorPlace
Wednesday, 24 April 2024
InvestorPlace
Tuesday, 14 November 2023
Seeking Alpha
Proactive Investors
Wednesday, 8 November 2023
Proactive Investors
Tuesday, 10 October 2023
InvestorPlace
Wednesday, 16 August 2023
InvestorPlace
Thursday, 10 August 2023
Seeking Alpha
Proactive Investors
Thursday, 3 August 2023
GlobeNewsWire
Tuesday, 1 August 2023
InvestorPlace
Sunday, 30 July 2023
InvestorPlace
Tuesday, 18 July 2023
Proactive Investors
Tuesday, 27 June 2023
Proactive Investors
InvestorPlace
  • What's the price of Predictive Oncology stock today?

    One share of Predictive Oncology stock can currently be purchased for approximately $0.9.

  • When is Predictive Oncology's next earnings date?

    Unfortunately, Predictive Oncology's (POAI) next earnings date is currently unknown.

  • Does Predictive Oncology pay dividends?

    No, Predictive Oncology does not pay dividends.

  • How much money does Predictive Oncology make?

    Predictive Oncology has a market capitalization of 4.56M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 18.24% to 1.78M US dollars.

  • What is Predictive Oncology's stock symbol?

    Predictive Oncology Inc. is traded on the NASDAQ under the ticker symbol "POAI".

  • What is Predictive Oncology's primary industry?

    Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.

  • How do i buy shares of Predictive Oncology?

    Shares of Predictive Oncology can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Predictive Oncology's key executives?

    Predictive Oncology's management team includes the following people:

    • Mr. Robert L. Myers Chief Financial Officer & Sec.(age: 70, pay: $327,840)
    • Mr. J. Melville Engle Chairman & Chief Executive Officer(age: 75, pay: $3,000)
  • How many employees does Predictive Oncology have?

    As Jul 2024, Predictive Oncology employs 34 workers, which is 10% more then previous quarter.

  • When Predictive Oncology went public?

    Predictive Oncology Inc. is publicly traded company for more then 15 years since IPO on 3 May 2010.

  • What is Predictive Oncology's official website?

    The official website for Predictive Oncology is predictive-oncology.com.

  • Where are Predictive Oncology's headquarters?

    Predictive Oncology is headquartered at 2915 Commers Drive, Eagan, MN.

  • How can i contact Predictive Oncology?

    Predictive Oncology's mailing address is 2915 Commers Drive, Eagan, MN and company can be reached via phone at +65 13894800.

Predictive Oncology company profile:

Predictive Oncology Inc.

predictive-oncology.com
Exchange:

NASDAQ

Full time employees:

34

Industry:

Medical - Instruments & Supplies

Sector:

Healthcare

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.

2915 Commers Drive
Eagan, MN 55121

CIK: 0001446159
ISIN: US74039M3097
CUSIP: 74039M200